A Concise, Selective Synthesis of the Polyketide Spacer Domain of a Potent Bryostatin Analogue
摘要:
[GRAPHICS]A concise, asymmetric synthesis of the polyketide spacer domain portion (C1-C13) of a highly potent bryostatin analogue was developed. The route utilizes asymmetric hydrogenation methodology to install the C3, C5, and C11 stereocenters, while a substrate directed syn reduction sets the C9 stereocenter. The spacer domain 1 is obtained in 10 steps with a 25% overall yield and is readily incorporated into the synthesis of 2.
A Concise, Selective Synthesis of the Polyketide Spacer Domain of a Potent Bryostatin Analogue
摘要:
[GRAPHICS]A concise, asymmetric synthesis of the polyketide spacer domain portion (C1-C13) of a highly potent bryostatin analogue was developed. The route utilizes asymmetric hydrogenation methodology to install the C3, C5, and C11 stereocenters, while a substrate directed syn reduction sets the C9 stereocenter. The spacer domain 1 is obtained in 10 steps with a 25% overall yield and is readily incorporated into the synthesis of 2.
Biologically active compounds related to the bryostatin family of compounds, having simplified spacer domains and/or improved recognition domains are disclosed, including methods of preparing and utilizing the same.
Bryostatin Analogues, Synthetic Methods and Uses
申请人:The Board of Trustees of the Leland Stanford Juni
公开号:US20130123518A1
公开(公告)日:2013-05-16
Biologically active compounds related to the bryostatin family of compounds, having simplified spacer domains and/or improved recognition domains are disclosed, including methods of preparing and utilizing the same.
US8735609B2
申请人:——
公开号:US8735609B2
公开(公告)日:2014-05-27
A Concise, Selective Synthesis of the Polyketide Spacer Domain of a Potent Bryostatin Analogue
作者:Paul A. Wender、Alexander V. W. Mayweg、Christopher L. VanDeusen
DOI:10.1021/ol0272390
日期:2003.2.1
[GRAPHICS]A concise, asymmetric synthesis of the polyketide spacer domain portion (C1-C13) of a highly potent bryostatin analogue was developed. The route utilizes asymmetric hydrogenation methodology to install the C3, C5, and C11 stereocenters, while a substrate directed syn reduction sets the C9 stereocenter. The spacer domain 1 is obtained in 10 steps with a 25% overall yield and is readily incorporated into the synthesis of 2.